Log in to save to my catalogue

A Review of Nebivolol Pharmacology and Clinical Evidence

A Review of Nebivolol Pharmacology and Clinical Evidence

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4541699

A Review of Nebivolol Pharmacology and Clinical Evidence

About this item

Full title

A Review of Nebivolol Pharmacology and Clinical Evidence

Publisher

Cham: Springer International Publishing

Journal title

Drugs (New York, N.Y.), 2015-08, Vol.75 (12), p.1349-1371

Language

English

Formats

Publication information

Publisher

Cham: Springer International Publishing

More information

Scope and Contents

Contents

Nebivolol is a highly selective β
1
-adrenergic receptor antagonist with a pharmacologic profile that differs from those of other drugs in its class. In addition to cardioselectivity mediated via β
1
receptor blockade, nebivolol induces nitric oxide-mediated vasodilation by stimulating endothelial nitric oxide synthase via β
3
ago...

Alternative Titles

Full title

A Review of Nebivolol Pharmacology and Clinical Evidence

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4541699

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4541699

Other Identifiers

ISSN

0012-6667

E-ISSN

1179-1950

DOI

10.1007/s40265-015-0435-5

How to access this item